• Policy
• Lily's orphan drug 'Jaypirca' receives conditional approval
• by Lee, Hye-Kyung Aug 30, 2024 05:50am

• Policy
• Reimb standards set for biliary tract cancer drug Pemazyre
• by Lee, Tak-Sun Aug 30, 2024 05:50am

• Policy
• Prices of Dukarb, Rosuzet cut 3 yrs through PVA
• by Lee, Tak-Sun Aug 30, 2024 05:49am

• Policy
• Will RWD-based reimb agreements be more beneficial?
• by Lee, Tak-Sun Aug 29, 2024 04:31am

• Policy
• Price of 17 items cut 30% during Type C PVA negotiations
• by Lee, Tak-Sun Aug 28, 2024 05:52am

• Policy
• MFDS to review side effects relief imposed on companies
• by Lee, Jeong-Hwan Aug 28, 2024 05:52am

• Policy
• SK Chemicals strengthens migraine drug lineup with Suvexx
• by Lee, Tak-Sun Aug 27, 2024 05:50am

• Policy
• Eliquis generics re-enter the market, 35 reimbursed drugs
• by Lee, Tak-Sun Aug 26, 2024 05:46am

• Policy
• Hanmi faces competition from cheaper Zytiga generic drug
• by Lee, Tak-Sun Aug 26, 2024 05:45am

• Policy
• DREC to review the COVID-19 drug Paxlovid a week earlier
• by Lee, Tak-Sun Aug 23, 2024 06:17am